Background:
Patients with schizophrenia spectrum disorders (SSD) tend to lack insight, which is linked to poor outcomes. The effect size of previous treatments on insight changes in SSD has been small. Metacognitive interventions may improve insight in SSD, although this remains unproved.
Methods:
We carried out a systematic review and meta-analysis of randomized controlled trials (RCTs) to examine the effects of metacognitive interventions designed for SSD, namely Metacognitive Training (MCT) and Metacognitive Reflection and Insight Therapy (MERIT), on changes in cognitive and clinical insight at post-treatment and at follow-up.
Results:
Twelve RCTs, including 10 MCT RCTs (n = 717 participants) and two MERIT trials (n = 90), were selected, totalling N = 807 participants. Regarding cognitive insight six RCTs (n = 443) highlighted a medium effect of MCT on self-reflectiveness at post-treatment, d = 0.46, p < 0.01, and at follow-up, d = 0.30, p < 0.01. There was a small effect of MCT on self-certainty at post-treatment, d = -0.23, p = 0.03, but not at follow-up. MCT was superior to controls on an overall Composite Index of cognitive insight at post-treatment, d = 1.11, p < 0.01, and at follow-up, d = 0.86, p = 0.03, although we found evidence of heterogeneity. Of five MCT trials on clinical insight (n = 244 participants), which could not be meta-analysed, four of them favoured MCT compared v. control. The two MERIT trials reported conflicting results.
Conclusions:
Metacognitive interventions, particularly Metacognitive Training, appear to improve insight in patients with SSD, especially cognitive insight shortly after treatment. Further long-term RCTs are needed to establish whether these metacognitive interventions-related insight changes are sustained over a longer time period and result in better outcomes.
Citing Articles
Metacognitive processes, situational factors, and clinical decision-making in nursing education: a quantitative longitudinal study.
Wang F, Liu D, Zhang M
BMC Med Educ. 2024; 24(1):1530.
PMID: 39722024
PMC: 11670434.
DOI: 10.1186/s12909-024-06467-y.
Clinical subtypes of schizophrenia based on the discrepancies between objective performance on social cognition tasks and subjective difficulties in social cognition.
Uchino T, Akiyama H, Okubo R, Wada I, Aoki A, Nohara M
Schizophrenia (Heidelb). 2024; 10(1):94.
PMID: 39472633
PMC: 11522310.
DOI: 10.1038/s41537-024-00515-8.
Psychometric evaluation of the Arabic language version of the Birchwood Insight Scale in patients with schizophrenia.
Fekih-Romdhane F, Bitar Z, Al Mouzakzak F, Abilmona G, Dahdouh O, Hallit S
BMC Psychiatry. 2024; 24(1):233.
PMID: 38539115
PMC: 10976762.
DOI: 10.1186/s12888-024-05657-8.
Evidence-based psychosocial interventions in schizophrenia: a critical review.
Barlati S, Nibbio G, Vita A
Curr Opin Psychiatry. 2024; 37(3):131-139.
PMID: 38410981
PMC: 10990032.
DOI: 10.1097/YCO.0000000000000925.
Heterogeneity in Response to MCT and Psychoeducation: A Feasibility Study Using Latent Class Mixed Models in First-Episode Psychosis.
Ferrer-Quintero M, Fernandez D, Lopez-Carrilero R, Diaz-Cutraro L, Verdaguer-Rodriguez M, Garcia-Mieres H
Healthcare (Basel). 2022; 10(11).
PMID: 36360496
PMC: 9691095.
DOI: 10.3390/healthcare10112155.
Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial.
Lysaker P, Weiden P, Sun X, OSullivan A, McEvoy J
BMC Psychiatry. 2022; 22(1):574.
PMID: 36031632
PMC: 9420291.
DOI: 10.1186/s12888-022-04190-w.
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
Lopez-Morinigo J, Leucht S, Arango C
Pharmacopsychiatry. 2022; 55(5):233-245.
PMID: 35777418
PMC: 9458343.
DOI: 10.1055/a-1854-0185.
Metacognitive training for psychosis (MCT): past, present, and future.
Moritz S, Menon M, Balzan R, Woodward T
Eur Arch Psychiatry Clin Neurosci. 2022; 273(4):811-817.
PMID: 35338378
PMC: 8956140.
DOI: 10.1007/s00406-022-01394-9.
Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis: A Systematic Review and Meta-analysis.
Penney D, Sauve G, Mendelson D, Thibaudeau E, Moritz S, Lepage M
JAMA Psychiatry. 2022; 79(5):417-429.
PMID: 35320347
PMC: 8943641.
DOI: 10.1001/jamapsychiatry.2022.0277.
Investigating the Role of Insight, Decision-Making and Mentalizing in Functional Outcome in Schizophrenia: A Cross-Sectional Study.
Escobedo-Aedo P, Forjan-Gonzalez A, Martinez A, Ruiz-Ruano V, Sanchez-Alonso S, Mata-Iturralde L
Behav Sci (Basel). 2022; 12(2).
PMID: 35200280
PMC: 8868582.
DOI: 10.3390/bs12020028.
Improvement of Insight with Non-Invasive Brain Stimulation in Patients with Schizophrenia: A Systematic Review.
Blay M, Adam O, Bation R, Galvao F, Brunelin J, Mondino M
J Clin Med. 2022; 11(1).
PMID: 35011780
PMC: 8745271.
DOI: 10.3390/jcm11010040.
Co-occurring Deficits in Clinical and Cognitive Insight in Prolonged Schizophrenia-Spectrum Disorders: Relationship to Metacognitive Deficits.
Mervis J, Bonfils K, Cooper S, Wiesepape C, Lysaker P
Schizophr Bull Open. 2021; 2(1):sgab034.
PMID: 34901868
PMC: 8650079.
DOI: 10.1093/schizbullopen/sgab034.
Persons with first episode psychosis have distinct profiles of social cognition and metacognition.
Ferrer-Quintero M, Fernandez D, Lopez-Carrilero R, Birules I, Barajas A, Lorente-Rovira E
NPJ Schizophr. 2021; 7(1):61.
PMID: 34887442
PMC: 8660816.
DOI: 10.1038/s41537-021-00187-8.
Understanding the Influence of Personality Traits on Risk of Suicidal Behaviour in Schizophrenia Spectrum Disorders: A Systematic Review.
Canal-Rivero M, Ayesa-Arriola R, Setien-Suero E, Crespo-Facorro B, Arango C, Dutta R
J Clin Med. 2021; 10(19).
PMID: 34640622
PMC: 8509679.
DOI: 10.3390/jcm10194604.